| MiR-221/222 target the DNA methyltransferase MGMT in glioma cells C Quintavalle, D Mangani, G Roscigno, G Romano, A Diaz-Lagares, ... PloS one 8 (9), e74466, 2013 | 120 | 2013 |
| Endogenous glucocorticoid signaling regulates CD8+ T cell differentiation and development of dysfunction in the tumor microenvironment N Acharya, A Madi, H Zhang, M Klapholz, G Escobar, S Dulberg, ... Immunity 53 (3), 658-671. e6, 2020 | 108 | 2020 |
| T cell factor 1: A master regulator of the T cell response in disease G Escobar, D Mangani, AC Anderson Science immunology 5 (53), eabb9726, 2020 | 101 | 2020 |
| The network of immunosuppressive pathways in glioblastoma D Mangani, M Weller, P Roth Biochemical pharmacology 130, 1-9, 2017 | 95 | 2017 |
| CLA-supplemented diet accelerates experimental colorectal cancer by inducing TGF-β-producing macrophages and T cells TG Moreira, LS Horta, AC Gomes-Santos, RP Oliveira, N Queiroz, ... Mucosal Immunology 12 (1), 188-199, 2019 | 32 | 2019 |
| Limited role for transforming growth factor–β pathway activation-mediated escape from VEGF inhibition in murine glioma models D Mangani, M Weller, E Seyed Sadr, E Willscher, K Seystahl, ... Neuro-oncology 18 (12), 1610-1621, 2016 | 30 | 2016 |
| PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis TG Moreira, D Mangani, LM Cox, J Leibowitz, ELC Lobo, MA Oliveira, ... Nature Communications 12 (1), 4907, 2021 | 22 | 2021 |
| Emerging molecular networks in Burkitt's lymphoma D Mangani, A Roberti, F Rizzolio, A Giordano Journal of cellular biochemistry 114 (1), 35-38, 2013 | 12 | 2013 |
| Tumor immunogenicity dictates reliance on TCF1 in CD8+ T cells for response to immunotherapy G Escobar, K Tooley, JP Oliveras, L Huang, H Cheng, ML Bookstaver, ... Cancer cell 41 (9), 1662-1679. e7, 2023 | 8 | 2023 |
| Learning from the nexus of autoimmunity and cancer D Mangani, D Yang, AC Anderson Immunity 56 (2), 256-271, 2023 | 8 | 2023 |
| T cell factor 1: A master regulator of the T cell response in disease. Sci. Immunol. 5, eabb9726 G Escobar, D Mangani, AC Anderson | 7 | 2020 |
| Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19 T G. Moreira, CD Gauthier, L Murphy, TB Lanser, A Paul, KTF Matos, ... Proceedings of the National Academy of Sciences 120 (11), e2220272120, 2023 | 5 | 2023 |
| An endogenous glucocorticoid-cytokine signaling circuit promotes CD8+ T cell dysfunction in the tumor microenvironment N Acharya, A Madi, H Zhang, M Klapholz, E Christian, KO Dixon, G Fell, ... bioRxiv, 799759, 2019 | 2 | 2019 |
| Charting the cellular biogeography in colitis reveals fibroblast trajectories and coordinated spatial remodeling P Cadinu, KN Sivanathan, A Misra, RJ Xu, D Mangani, E Yang, JM Rone, ... Cell 187 (8), 2010-2028. e30, 2024 | 1 | 2024 |
| 964 Dynamic immune landscapes during melanoma progression reveal a role for endogenous opioids in driving T cell dysfunction D Mangani, L Huang, M Singer, R Li, R Barilla, G Escobar, K Tooley, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
| Tumor context dictates reliance on TCF1 for response to immunotherapy G Escobar, K Tooley, JP Oliveras, L Huang, H Cheng, C Xue, D Mangani, ... Cancer Research 83 (7_Supplement), 4157-4157, 2023 | | 2023 |
| Abstract B35: Tumor context dictates reliance on TCF1 for response to immunotherapy G Escobar, K Tooley, JP Oliveras, C Hanning, X Chang, D Mangani, ... Cancer Immunology Research 10 (12_Supplement), B35-B35, 2022 | | 2022 |
| 514 Tumor context dictates reliance on TCF1 for response to immunotherapy G Escobar, K Tooley, JP Oliveras, C Hanning, X Chang, D Mangani, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| Nasal anti-CD3 mAb (Foralumab) dampens CD3+ T effector function and decreases NKG7 in COVID-19 through a mechanism involving GIMAP-7 and TGFb1 T Moreira, C Gauthier, L Murphy, T Lanser, A Paul, K Matos, D Mangani, ... | | 2022 |
| Methods and compositions for the modulation of opioid signaling in the tumor microenvironment M Singer, A Regev, O Rozenblatt-Rosen, D Mangani, AC Anderson, ... US Patent App. 17/494,062, 2022 | | 2022 |
